|1||Active, not recruiting||
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa
|2||Enrolling by invitation||
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
† Study has passed its completion date and status has not been verified in more than two years.